Circulating vitamin D metabolite concentrations in childhood renal diseases

Chesney, Russell W.; Hamstra, Alan J.; Mazess, Richard B.; Rose, Philip; DeLuca, Hector F.
January 1982
Kidney International;Jan1982, Vol. 21 Issue 1, p65
Academic Journal
Circulating vitamin D metabolite concentrations in childhood renal diseases. Vitamin D metabolites were measured in children, untreated with glucocorticoids, who had renal disease. Two groups were defined in relation to endogenous creatinine clearance values: those with impaired clearance, 0 to 48 ml/min per 1.73 m² and those with unimpaired clearance, 75 to 150 ml/min per 1.73 ². Serum 1,25 (OH)2D was 16 ± (SD) 12 pg/ml in impaired patients (N = 24) and 48 ± 16 pg/ml in unimpaired patients (N = 18). The latter level is not different from healthy childhood controls (43 ± 12 pg/ml; N = 194). Serum samples of 25(OH)D2 and D3 were comparable in each group and not different from control values of 33.2 ± 10.3 ng/ml. Serum 24,25(OH)2D was 0.6 ± (SD) 0.14 ng/ml in patients with a clearance of < ml/min per 1.73 m², 1.39 ± 0.54 ng/ml in those with a clearance of 18 to 48 ml/min per 1.73 m², and 1.52 ± 0.91 ng/ml in patients without an impairment of clearance. Only patients with the lowest clearances had values different from controls values of 1.70 ± 0.57 ng/ml. In our study we suggest that a significant reduction in 24,25(OH)2D and 1,25(OH)2D are found at low clearance values in children with tubulointerstitial disease. Our study further suggests that a reduction in renal tubular mass is important in accounting for these changes in vitamin D metabolite values.


Related Articles

  • THE GIFT THAT SAVED MY LIFE. Cates, Tiffanie; Buchholz, Rachel // National Geographic World;Dec2001, Issue 316, p19 

    Relates the experience of student Tiffanie Cates on having a kidney disease in the United States. Information on the disease; How kidneys work; Kidney donor of Cates for her transplant; Life of Cates after the kidney dialysis.

  • Proteinuria and renal disease: prognostic value of urine dipstick testing for leukocytes. Koss, Shira; Perl, Ari; Wieder, Adinah; Frank, Rachel; Vento, Suzanne; Trachtman, Howard // Pediatric Nephrology;Apr2006, Vol. 21 Issue 4, p584 

    Proteinuria is utilized to screen for underlying kidney disease and serves as a marker of disease progression. The aim of this study was to test the hypothesis that patients with proteinuria will have a higher frequency of urine dipstick positive for leukocytes as an index of noninfectious renal...

  • influence of hyperfiltration on the measurement of urinary N-acetyl-β-D-glucosaminidase. Müller, D.; Sievers, E.; Eggert, P. // Pediatric Nephrology;1999, Vol. 13 Issue 6, p519 

    The measurement of urinary enzymes in patients with diabetes mellitus has become a useful additional test for the early detection of nephropathy. Controversy persists concerning methods of measurement since during early stages of insulin-dependent diabetes mellitus children develop the so-called...

  • Levels of urinary transforming growth factor β-1 in children with D+ hemolytic uremic syndrome. Caletti, María; Balestracci, Alejandro; Roy, Adriana // Pediatric Nephrology;Jun2010, Vol. 25 Issue 6, p1177 

    About 25–50% of survivors of the acute phase of postdiarrheal hemolytic uremic syndrome (D+ HUS) develop chronic renal disease. Transforming growth factor β-1 (TGFβ-1) is the main fibrogenic growth factor in humans, and there is a significant correlation between its levels and the...

  • Metabolomics in Adult and Pediatric Nephrology. Fanos, Vassilios; Fanni, Claudia; Ottonello, Giovanni; Noto, Antonio; Dessì, Angelica; Mussap, Michele // Molecules;May2013, Vol. 18 Issue 5, p4844 

    Metabolomics, the latest of the "omics" sciences, has a non-selective approach and can thus lead to the identification of all the metabolites (molecules < 1 kDa) in a biological system. The metabolomic profile can be considered the most predictive phenotype capable of evaluating epigenetic...

  • Intermittent or daily administration of 1-alpha calcidol for nephrectomised infants on peritoneal dialysis? Saarinen, Tuure T.; Arikoski, Pekka; Holmberg, Christer; Rönnholm, Kai // Pediatric Nephrology;Nov2007, Vol. 22 Issue 11, p1931 

    Secondary hyperparathyroidism and renal osteodystrophy are major problems in patients with end-stage renal failure and may result in poor growth in children on dialysis. Whether vitamin D sterols should be given intermittently or daily remains a controversial issue. We studied 16 bilaterally...

  • Effect of vitamin D metabolites on calcitriol degradative enzymes in renal failure. Patel, Sanjeevkumar R.; Hui Qiong Ke; Hsu, Chen H. // Kidney International;Feb1994, Vol. 45 Issue 2, p509 

    We have demonstrated that in renal failure calcitriol degradation is decreased and that administration of vitamin D metabolites increases the degradation. In this study, we measured intestinal 24- and 26-hydroxylase activities and the effects of chronic infusion (7 days) of vitamin D metabolites...

  • Effects of vitamin D metabolites on protein catabolism of muscle from uremic rats. Harter, Herschel R.; Birge, Stanley J.; Martin, Kevin J.; Klahr, Saulo; Karl, Irene E.; Tegtmeyer, Elise; Osborne, Dale F.; Howard, Thomas; Miller, Ruth // Kidney International;Mar1983, Vol. 23 Issue 3, p465 

    Epitrochlearis muscles obtained from normal male Sprague-Dawley rats used as controls (C) and rats with reduced renal mass (Nx) were incubated for 1 hr in Krebs-Ringer buffer containing 5 mM glucose with or without insulin, 25-hydroxycholecalciferol [25(OH)D3] or 1,25 dihydroxycholecalciferol...

  • The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study. Molina, Pablo; Górriz, José L.; Molina, Mariola D.; Peris, Ana; Beltrán, Sandra; Kanter, Julia; Escudero, Verónica; Romero, Ramón; Pallardó, Luis M. // Nephrology Dialysis Transplantation;Jan2014, Vol. 29 Issue 1, p97 

    Background Growing evidence indicates that vitamin D receptor activation may have antiproteinuric effects. We aimed to evaluate whether vitamin D supplementation with daily cholecalciferol could reduce albuminuria in proteinuric chronic kidney disease (CKD) patients. Methods This 6-month...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics